BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7116760)

  • 1. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
    Keller E; Hoppe-Seyler G; Schollmeyer P
    Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G; Bravo I; Ibarra N; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of albumin and furosemide in patients with the nephrotic syndrome.
    Fliser D; Zurbrüggen I; Mutschler E; Bischoff I; Nussberger J; Franek E; Ritz E
    Kidney Int; 1999 Feb; 55(2):629-34. PubMed ID: 9987087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
    Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
    Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats.
    Kirchner KA; Voelker JR; Brater DC
    J Am Soc Nephrol; 1992 Jan; 2(7):1201-7. PubMed ID: 1591361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of dextran combination with flurosemide on nephrotic syndrome].
    Chen X; Liu H; Ma ZH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):374-6. PubMed ID: 12536743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary protein binding, kinetics, and dynamics of furosemide in nephrotic patients.
    Smith DE; Hyneck ML; Berardi RR; Port FK
    J Pharm Sci; 1985 Jun; 74(6):603-7. PubMed ID: 4020645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
    Prandota J
    Dev Pharmacol Ther; 1982; 5(1-2):98-108. PubMed ID: 7151641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
    Minutolo R; Andreucci M; Balletta MM; Russo D
    Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
    Agarwal R; Gorski JC; Sundblad K; Brater DC
    J Am Soc Nephrol; 2000 Jun; 11(6):1100-1105. PubMed ID: 10820174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
    Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
    Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
    Na KY; Han JS; Kim YS; Ahn C; Kim S; Lee JS; Bae KS; Jang IJ; Shin SG; Huh W; Jeon US
    J Korean Med Sci; 2001 Aug; 16(4):448-54. PubMed ID: 11511790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
    Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
    J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Prandota J
    Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic study of intravenous furosemide in nephrotic syndrome in children].
    Lenoir G; Halter D; Seligman R; Dreuz C
    Arch Fr Pediatr; 1978 Feb; 35(2):187-97. PubMed ID: 637676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furosemide disposition in cirrhosis.
    Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
    Kirchner KA; Voelker JR; Brater DC
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1097-101. PubMed ID: 2319462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.